BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 17959774)

  • 1. Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism.
    Pitteloud N; Zhang C; Pignatelli D; Li JD; Raivio T; Cole LW; Plummer L; Jacobson-Dickman EE; Mellon PL; Zhou QY; Crowley WF
    Proc Natl Acad Sci U S A; 2007 Oct; 104(44):17447-52. PubMed ID: 17959774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum.
    Cole LW; Sidis Y; Zhang C; Quinton R; Plummer L; Pignatelli D; Hughes VA; Dwyer AA; Raivio T; Hayes FJ; Seminara SB; Huot C; Alos N; Speiser P; Takeshita A; Van Vliet G; Pearce S; Crowley WF; Zhou QY; Pitteloud N
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3551-9. PubMed ID: 18559922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss-of-function mutations in the genes encoding prokineticin-2 or prokineticin receptor-2 cause autosomal recessive Kallmann syndrome.
    Abreu AP; Trarbach EB; de Castro M; Frade Costa EM; Versiani B; Matias Baptista MT; Garmes HM; Mendonca BB; Latronico AC
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4113-8. PubMed ID: 18682503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kallmann syndrome caused by mutations in the PROK2 and PROKR2 genes: pathophysiology and genotype-phenotype correlations.
    Sarfati J; Dodé C; Young J
    Front Horm Res; 2010; 39():121-132. PubMed ID: 20389090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of prokineticins in the pathogenesis of hypogonadotropic hypogonadism.
    Abreu AP; Kaiser UB; Latronico AC
    Neuroendocrinology; 2010; 91(4):283-90. PubMed ID: 20502053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The complex genetics of Kallmann syndrome: KAL1, FGFR1, FGF8, PROKR2, PROK2, et al.
    Hardelin JP; Dodé C
    Sex Dev; 2008; 2(4-5):181-93. PubMed ID: 18987492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice.
    Falardeau J; Chung WC; Beenken A; Raivio T; Plummer L; Sidis Y; Jacobson-Dickman EE; Eliseenkova AV; Ma J; Dwyer A; Quinton R; Na S; Hall JE; Huot C; Alois N; Pearce SH; Cole LW; Hughes V; Mohammadi M; Tsai P; Pitteloud N
    J Clin Invest; 2008 Aug; 118(8):2822-31. PubMed ID: 18596921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biallelic mutations in the prokineticin-2 gene in two sporadic cases of Kallmann syndrome.
    Leroy C; Fouveaut C; Leclercq S; Jacquemont S; Boullay HD; Lespinasse J; Delpech M; Dupont JM; Hardelin JP; Dodé C
    Eur J Hum Genet; 2008 Jul; 16(7):865-8. PubMed ID: 18285834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel function of miR-3195 for mutant PROK2 (c.223-4C>A) degradation.
    Zhou S; Li P
    Cell Biol Int; 2021 Feb; 45(2):404-410. PubMed ID: 33140874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism.
    Pitteloud N; Acierno JS; Meysing A; Eliseenkova AV; Ma J; Ibrahimi OA; Metzger DL; Hayes FJ; Dwyer AA; Hughes VA; Yialamas M; Hall JE; Grant E; Mohammadi M; Crowley WF
    Proc Natl Acad Sci U S A; 2006 Apr; 103(16):6281-6. PubMed ID: 16606836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2.
    Dodé C; Teixeira L; Levilliers J; Fouveaut C; Bouchard P; Kottler ML; Lespinasse J; Lienhardt-Roussie A; Mathieu M; Moerman A; Morgan G; Murat A; Toublanc JE; Wolczynski S; Delpech M; Petit C; Young J; Hardelin JP
    PLoS Genet; 2006 Oct; 2(10):e175. PubMed ID: 17054399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triallelic digenic mutation in the prokineticin 2 and GNRH receptor genes in two brothers with normosmic congenital hypogonadotropic hypogonadism.
    Méndez JP; Zenteno JC; Coronel A; Soriano-Ursúa MA; Valencia-Villalvazo EY; Soderlund D; Coral-Vázquez RM; Canto P
    Endocr Res; 2015; 40(3):166-71. PubMed ID: 25531638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical manifestations of impaired GnRH neuron development and function.
    Kim HG; Bhagavath B; Layman LC
    Neurosignals; 2008; 16(2-3):165-82. PubMed ID: 18253056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of autosomal genes in Kallmann syndrome: genotype-phenotype correlations and neuroendocrine characteristics.
    Oliveira LM; Seminara SB; Beranova M; Hayes FJ; Valkenburgh SB; Schipani E; Costa EM; Latronico AC; Crowley WF; Vallejo M
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1532-8. PubMed ID: 11297579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kallmann syndrome: phenotype and genotype of hypogonadotropic hypogonadism.
    Stamou MI; Georgopoulos NA
    Metabolism; 2018 Sep; 86():124-134. PubMed ID: 29108899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrum of phenotype and genotype of congenital isolated hypogonadotropic hypogonadism in Asian Indians.
    Nair S; Jadhav S; Lila A; Jagtap V; Bukan A; Pandit R; Ekbote A; Dharmalingam M; Kumar P; Kalra P; Gandhi P; Walia R; Sankhe S; Raghavan V; Shivane V; Menon P; Bandgar T; Shah N
    Clin Endocrinol (Oxf); 2016 Jul; 85(1):100-9. PubMed ID: 26708526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital Hypogonadotropic Hypogonadism with Anosmia and Gorlin Features Caused by a PTCH1 Mutation Reveals a New Candidate Gene for Kallmann Syndrome.
    Barraud S; Delemer B; Poirsier-Violle C; Bouligand J; Mérol JC; Grange F; Higel-Chaufour B; Decoudier B; Zalzali M; Dwyer AA; Acierno JS; Pitteloud N; Millar RP; Young J
    Neuroendocrinology; 2021; 111(1-2):99-114. PubMed ID: 32074614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the prokineticin 2 pathway in human reproduction: evidence from the study of human and murine gene mutations.
    Martin C; Balasubramanian R; Dwyer AA; Au MG; Sidis Y; Kaiser UB; Seminara SB; Pitteloud N; Zhou QY; Crowley WF
    Endocr Rev; 2011 Apr; 32(2):225-46. PubMed ID: 21037178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and molecular aspects of congenital isolated hypogonadotropic hypogonadism].
    Tusset C; Trarbach EB; Silveira LF; Beneduzzi D; Montenegro L; Latronico AC
    Arq Bras Endocrinol Metabol; 2011 Nov; 55(8):501-11. PubMed ID: 22218430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PROKR2 and PROK2 mutations cause isolated congenital anosmia without gonadotropic deficiency.
    Moya-Plana A; Villanueva C; Laccourreye O; Bonfils P; de Roux N
    Eur J Endocrinol; 2013 Jan; 168(1):31-7. PubMed ID: 23082007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.